148 related articles for article (PubMed ID: 27595992)
1. A high throughput serum bactericidal assay for antibodies to Haemophilus influenzae type b.
Kim HW; Kim KH; Kim J; Nahm MH
BMC Infect Dis; 2016 Sep; 16(1):473. PubMed ID: 27595992
[TBL] [Abstract][Full Text] [Related]
2. Evaluation and validation of a serum bactericidal antibody assay for Haemophilus influenzae type b and the threshold of protection.
Townsend K; Ladhani SN; Findlow H; Borrow R
Vaccine; 2014 Sep; 32(43):5650-6. PubMed ID: 25138290
[TBL] [Abstract][Full Text] [Related]
3. Children with Haemophilus influenzae type b (Hib) vaccine failure have long-term bactericidal antibodies against virulent Hib strains with multiple capsular loci.
Townsend-Payne K; Ladhani SN; Findlow H; Slack M; Borrow R
Vaccine; 2016 Jul; 34(34):3931-4. PubMed ID: 27317452
[TBL] [Abstract][Full Text] [Related]
4. Increased serum bactericidal activity of autologous serum in C2 deficiency after vaccination against Haemophilus influenzae type b, and further support for an MBL-dependent C2 bypass mechanism.
Jönsson G; Hansson C; Mellhammar L; Gullstrand B; Bengtsson AA; Sahl C; Skattum L
Vaccine; 2021 Feb; 39(8):1297-1302. PubMed ID: 33509693
[TBL] [Abstract][Full Text] [Related]
5. Safety and antibody persistence following Haemophilus influenzae type b conjugate or pneumococcal polysaccharide vaccines given before pregnancy in women of childbearing age and their infants.
Santosham M; Englund JA; McInnes P; Croll J; Thompson CM; Croll L; Glezen WP; Siber GR
Pediatr Infect Dis J; 2001 Oct; 20(10):931-40. PubMed ID: 11642626
[TBL] [Abstract][Full Text] [Related]
6. Immunogenicity and safety of two doses of catch-up immunization with Haemophilus influenzae type b conjugate vaccine in Indian children living with HIV.
Arya BK; Bhattacharya SD; Sutcliffe CG; Saha MK; Bhattacharyya S; Niyogi SK; Moss WJ; Panda S; Das RS; Mallick M; Mandal S
Vaccine; 2016 Apr; 34(19):2267-74. PubMed ID: 26988256
[TBL] [Abstract][Full Text] [Related]
7. Haemophilus influenzae type b vaccine failure in children is associated with inadequate production of high-quality antibody.
Lee YC; Kelly DF; Yu LM; Slack MP; Booy R; Heath PT; Siegrist CA; Moxon RE; Pollard AJ
Clin Infect Dis; 2008 Jan; 46(2):186-92. PubMed ID: 18171249
[TBL] [Abstract][Full Text] [Related]
8. Measurement of serum bactericidal activity specific for Haemophilus influenzae type b by using a chromogenic and fluorescent metabolic indicator.
Romero-Steiner S; Spear W; Brown N; Holder P; Hennessy T; Gomez De Leon P; Carlone GM
Clin Diagn Lab Immunol; 2004 Jan; 11(1):89-93. PubMed ID: 14715550
[TBL] [Abstract][Full Text] [Related]
9. Immunologic response to Haemophilus influenzae type b (Hib) conjugate vaccine and risk factors for carriage among Hib carriers and noncarriers in Southwestern Alaska.
Baggett HC; Hennessy TW; Bulkow L; Romero-Steiner S; Hurlburt D; Holder P; Parkinson AJ; Singleton RJ; Levine O; Carlone GM; Butler JC
Clin Vaccine Immunol; 2006 Jun; 13(6):620-6. PubMed ID: 16760318
[TBL] [Abstract][Full Text] [Related]
10. Safety and immunogenocity of a novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroups A and C-tetanus-toxoid conjugate vaccine in healthy Chinese children aged 6 months to 5 years old.
Hu JL; Tao H; Li JX; Dai WM; Song B; Sun JF; Liu P; Tang J; Liu WY; Wang SY; Zhu FC
Hum Vaccin Immunother; 2015; 11(5):1120-8. PubMed ID: 25833163
[TBL] [Abstract][Full Text] [Related]
11. The development of a new heptavalent diphtheria-tetanus-whole cell pertussis-hepatitis B-Haemophilus influenzae type b-Neisseria meningitidis serogroups A and C vaccine: a randomized dose-ranging trial of the conjugate vaccine components.
Gatchalian S; Palestroque E; De Vleeschauwer I; Han HH; Poolman J; Schuerman L; Dobbelaere K; Boutriau D
Int J Infect Dis; 2008 May; 12(3):278-88. PubMed ID: 17981067
[TBL] [Abstract][Full Text] [Related]
12. Lot-to-lot consistency, safety and immunogenicity of 3 lots of Haemophilus influenzae type b conjugate vaccine: results from a phase III randomized, multicenter study in infants.
Klein NP; Abu-Elyazeed R; Cornish M; Leonardi ML; Weiner LB; Silas PE; Grogg SE; Varman M; Frenck RW; Cheuvart B; Baine Y; Miller JM; Leyssen M; Mesaros N; Roy-Ghanta S
Vaccine; 2017 Jun; 35(28):3564-3574. PubMed ID: 28536030
[TBL] [Abstract][Full Text] [Related]
13. The impact of vaccines on pneumonia: key lessons from Haemophilus influenzae type b conjugate vaccines.
Gessner BD; Adegbola RA
Vaccine; 2008 Jun; 26 Suppl 2():B3-8. PubMed ID: 18793604
[TBL] [Abstract][Full Text] [Related]
14. Comparison of serum bactericidal and antibody titers induced by two Haemophilus influenzae type b conjugate vaccines: A phase III randomized double-blind study.
Akeda Y; Koizumi Y; Takanami Y; Sumino S; Hattori Y; Sugizaki K; Mitsuya N; Oishi K
Vaccine; 2018 Mar; 36(12):1528-1532. PubMed ID: 29459064
[TBL] [Abstract][Full Text] [Related]
15. Circulating innate and adaptive immunity against anti-Haemophilus influenzae type b.
Zarei AE; Linjawi MH; Redwan EM
Hum Antibodies; 2019; 27(3):201-212. PubMed ID: 30958343
[TBL] [Abstract][Full Text] [Related]
16. Protective immunogenicity of Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine in children who failed to respond to prior invasive H. influenzae type b disease.
Berthet F; Prehn A; Suter R; Ethevenaux C; Seger RA
Pediatr Allergy Immunol; 1998 Aug; 9(3):156-60. PubMed ID: 9814731
[TBL] [Abstract][Full Text] [Related]
17. Antibodies prevalence against Haemophilus influenzae type b in Jeddah population, Saudi Arabia. I. Total antibodies.
Zarei AE; Redwan EM
Hum Antibodies; 2018; 26(4):225-235. PubMed ID: 29945350
[TBL] [Abstract][Full Text] [Related]
18. Concentration and avidity of anti-Haemophilus influenzae type b (Hib) antibodies in serum samples obtained from patients for whom Hib vaccination failed.
Breukels MA; Jol-van der Zijde E; van Tol MJ; Rijkers GT
Clin Infect Dis; 2002 Jan; 34(2):191-7. PubMed ID: 11740707
[TBL] [Abstract][Full Text] [Related]
19. A randomized, controlled, blinded study of the safety and immunogenicity of Haemophilus influenzae type b conjugate vaccine injected at different intramuscular sites in Chinese infants.
Shi N; Luo F; Li L; Zheng D; Zhang Z; Wang Z; Yang L; Liu Z; Ai X; Bai Y; Lu Q
Hum Vaccin Immunother; 2013 Nov; 9(11):2311-5. PubMed ID: 23842003
[TBL] [Abstract][Full Text] [Related]
20. Characterization of immune response as an indicator of Haemophilus influenzae type b vaccine efficacy.
Madore DV
Pediatr Infect Dis J; 1998 Sep; 17(9 Suppl):S207-10. PubMed ID: 9781765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
